CHYM
Research Snapshot
Static fundamentals, valuation context, and investor signals for Chime Financial, Inc. (CHYM).
DCF ready
Valuation
N/A
EV/FCF, N/A FCF yield
Quality
-72.1%
ROIC, 1.5% FCF margin
Growth
N/A
5Y sales (revenue) CAGR
Balance sheet
0.0x
Debt/equity, 4.5x current ratio
Superinvestors
3
Top: Samantha McLemore (2.0%)
Strengths to research
- Debt/equity looks manageable at 0.0x.
- 3 tracked superinvestors report a position.
Watchouts
- Valuation multiples are limited or unavailable.
Annual data: 3 periods
Quarterly data: 8 periods
Stock snapshot: May 25, 2026
Static dataset: May 25, 2026
Quality Scorecard
Build-time composite score for CHYM.
Grade F
7
/ 100
Financial Charts
No financial data available for CHYM (annual).
3 superinvestors own CHYM
Current quarter ownership and quarter-over-quarter share changes.
Superinvestor ownership
| Fund | Shares | Value | % Portfolio | QoQ Change |
|---|---|---|---|---|
| Chase Coleman Tiger Global Management | 11,081,780 | $208M | 0.91% | 0.0% |
| Samantha McLemore Patient Capital Management | 2,882,016 | $54M | 2.01% | 0.0% |
| Christopher Davis Davis Advisors | 2,539,206 | $48M | 0.22% | 0.0% |